Lv1
40 积分 2024-07-10 加入
Top advances of the year: Small cell lung cancer
2天前
已完结
Pharmacokinetics, pharmacodynamics, and tolerability of single ascending doses of RCT-18 in Chinese patients with rheumatoid arthritis
1个月前
已完结
B-cell depletion in autoimmune diseases
1个月前
已完结
Autoimmune disease is the next frontier for CAR T cell therapy
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
2个月前
已完结
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
3个月前
已完结
Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus
3个月前
已完结
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
3个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
6个月前
已完结
皖公网安备34019202002308
